Question 1

What is the catalog number for 2-Bromo-1-chloro-3-methoxybenzene?

Accepted Answer

The catalog number for 2-Bromo-1-chloro-3-methoxybenzene is 415656.

Question 2

What sizes are available for 2-Bromo-1-chloro-3-methoxybenzene?

Accepted Answer

2-Bromo-1-chloro-3-methoxybenzene is available in the following size(s): 25 mg, 50 mg.

Question 3

How many pack sizes does 2-Bromo-1-chloro-3-methoxybenzene come in?

Accepted Answer

2-Bromo-1-chloro-3-methoxybenzene is available in 2 different pack sizes.

Question 4

Is 2-Bromo-1-chloro-3-methoxybenzene in stock?

Accepted Answer

2-Bromo-1-chloro-3-methoxybenzene is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

Can this product be used for diagnostic or therapeutic purposes?

Accepted Answer

No. This product, like all items we supply, is intended for research laboratory use only and must not be used for diagnostics, therapeutics, treatment, or consumption by humans or animals.

Question 6

What is the shelf life of this product?

Accepted Answer

Shelf life and expiration dates vary by product and are shown on the product listing and label. Products used beyond their expiration date are not eligible for performance-related returns or refunds, so please check the lot number and expiry before use.

Question 7

What expression system was used for this recombinant protein?

Accepted Answer

The expression system, such as E. coli, HEK293, or insect cells, is listed on the datasheet under production details, which can affect post-translational modifications relevant to your application.

2-Bromo-1-chloro-3-methoxybenzene

Product Specifications

Available Sizes

Frequently Asked Questions

Explore Other Products

APOBEC3D (NM_152426) Human Over-expression Lysate

Human CD47 Recombinant Rabbit monoclonal Antibody

DERL3 (N-term) Rabbit Polyclonal Antibody

Melanoma Marker (HMB45 + M2-7C10 + M2-9E3 + T311), CF640R conjugate, 0.1mg/mL

DNALI1 (C-term) Rabbit Polyclonal Antibody

ZG16B Human Gene Knockout Kit (CRISPR)